Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 167 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 832. Clear
Clear
Q3
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
FORBES-TATE for NOVARTIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Trade (domestic/foreign), Budget/Appropriations, Copyright/Patent/Trademark
View →
Q3
AARP for AARP
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Agriculture, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q3
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q3
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q3
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q3
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q3
HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q3
ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS
3rd Quarter (July 1 - Sep 30) 2025 · South Carolina · House · Senate · $23,000.00 income
Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code
View →
Q3
HORIZON GOVERNMENT AFFAIRS for PHRMA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View →
2A
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q2
HARNED STRATEGIES LLC for JOB CREATORS NETWORK
2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate · $7,500.00 income
Unemployment, Budget/Appropriations, Education, Health Issues
View →
Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
EMD SERONO, INC. for EMD SERONO INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q2
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Agriculture
View →
Q2
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q2
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
2A
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Taxation/Internal Revenue Code, Banking, Budget/Appropriations, Civil Rights/Civil Liberties
View →
Q2
DLA PIPER LLP (US) for BIOGEN, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products
View →
Q2
WILLIAMS AND JENSEN, PLLC for PHRMA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Budget/Appropriations, Defense, Trade (domestic/foreign)
View →
Previous Page 5 of 7 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem